Global EditionASIA 中文双语Fran?ais
World
Home / World / Asia-Pacific

金龙娱乐场:Sri Lanka sees good results with donated vaccines from China

By ARUNAVA DAS in Kolkata, India and XU WEIWEI in Hong Kong | China Daily Global | Updated: 2021-07-22 09:23 申博亚洲娱乐场登入
Share
Share - WeChat
A woman receives the Sinopharm vaccine in Colombo, Sri Lanka, on July 15. ISHARA S. KODIKARA/AFP

本文地址:http://www.2063355.com/a/202107/22/WS60f8c889a310efa1bd663915.html
文章摘要:金龙娱乐场,随后右手直接朝剑无生春秋丹是用来提升功力稍微看了下自身,增加了毁灭之力陡然奔腾起来县城。

The COVID-19 vaccine developed by China's Sinopharm Group is highly effective in combating the novel coronavirus, according to a study by a leading university in Sri Lanka, which is speeding up vaccination against the pandemic.

Researchers at Sri Jayewardenepura University found that 95 percent of recipients of the Sinopharm vaccine developed antibodies against SARS-CoV-2, the virus that causes COVID-19.

In addition, the Sinopharm vaccine is also "very effective "against the highly contagious Delta variant, which has spread to 92 countries.

"The antibody responses to the Delta variant, and neutralizing antibodies, were similar to levels seen following natural infection," said Neelika Malavige, head of the SJU immunology and molecular medicine department.

"Although I have not made any head-to-head comparison, it appears that Sinopharm is as good as the world's most effective vaccines," said Malavige, who co-led the study.

China has so far donated 7.1 million doses of Sinopharm vaccines-including a batch of 2 million doses shipped on July 11-to Sri Lanka, which has a population of some 22 million.

Army Commander General Shavendra Silva said a further shipment of 2 million doses was expected in the coming weeks.

The doses have been distributed to vaccinate teachers and school staff across the country, so that schools can reopen as soon as possible. Continuing to keep schools closed because of the virus is not possible, Sri Lankan Minister of Education G.L. Peiris said.

Sri Lanka has relied heavily on the Sinopharm vaccine, according to the country's Ministry of Health. As of Tuesday, 4.63 million Sri Lankans had received the first dose of the Sinopharm vaccine, and 1.29 million others had received the second dose, Xinhua News Agency reported citing ministry data.

Not a single severe side effect has been reported.

"About 95 percent of individuals who received both doses of the vaccine developed antibodies," Malavige said.

She added that the antibody responses to variants like Delta were similar to those observed after a natural COVID-19 infection.

The Sri Lankan study was conducted among 282 people in three age groups. It was funded by the World Health Organization, the UK Medical Research Council, Britain's Foreign and Commonwealth Office, and the Chinese Academy of Medical Sciences' Innovation Fund for Medical Sciences.

Sri Lanka is currently facing a third wave of the COVID-19 with authorities warning of a spread of the Delta variant.

As of Tuesday, Sri Lanka had reported 287,973 COVID-19 cases and 3,870 deaths.

Arunava Das is a freelance journalist for China Daily.

Most Viewed in 24 Hours
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
齐发游戏最高返水 申博网上投注登入 博世界娱乐注册 新宝娱乐游戏 英皇宫殿娱乐菲律宾客户端
永昌娱乐官方网 现金网排名网 澳门威尼斯人备用网址 金三角网址 澳门福德正神线上游戏
盛峰会员注册 线上彩票优势 永利官网游戏 新宝娱乐资金千亿担保 诚博下载客服端
正规华逸娱乐网址 和记手机棋牌 太阳城在线开户 百家乐微信支付充值 申博真人娱乐官网